Tumors generated using MMP9 shRNA-treated cancer cells were smaller and/or less metastatic than tumors generated with control cells [54, 114], and injection of MMP9-targeted siRNA into established tumors decreased tumor growth [115, 116]. This evidence concerns the gene MMP9 and neoplasm.